Sanofi: Yellow Fever trials

The registry lists 10 Yellow Fever studies with Sanofi as lead sponsor. 0 are open to participants now and 5 have results posted.

Phase 1 1Phase 2 4Phase 3 4No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and AsiaActive, not recruitingNCT05011123Phase 2Results posted
• Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USAActive, not recruitingNCT04942210Phase 2Results posted
• Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever VaccineCompletedNCT01488890Phase 2Results posted
• Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy ToddlersCompletedNCT01436396Phase 3Results posted
• Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)CompletedNCT00982137Phase 2Results posted
• Phase 3 Single Arm, Open Study on vYF in AdultsCompletedNCT07222059Phase 3
• A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric PopulationActive, not recruitingNCT07103148Phase 3
• Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in AdultsCompletedNCT07002060Phase 3
• Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in AdultsCompletedNCT04142086Phase 1
• Passive Enhanced Safety Surveillance of Stamaril® Vaccine in KoreaCompletedNCT03541694